28501006|t|Liquid chromatography-mass spectrometry -based quantitative proteomics analysis reveals chondroprotective effects of astragaloside IV in interleukin-1β - induced SW1353 chondrocyte-like cells
28501006|a|Chondrocyte apoptosis played a key role on the progression of Osteoarthritis (OA). Safe and effective drugs are urgently needed for the treatment of OA. Previous study reported that Astragaloside IV (ASG-IV) had exerted a protective effect against articular cartilage degeneration by promoting rapid proliferation of chondrocyte. Therefore, the aim of our study is to explore the effects and mechanisms of ASG-IV in chondrocyte apoptosis. Isobaric Tags For Relative And Absolute Quantitation (iTRAQ)-based quantitative proteomics was used to quantitatively detect and map proteins in SW1353 chondrocyte-like cells pre-treated with ASG-IV or interleukin-1β (IL-1β) or ASG-IV + IL-1β. The iTRAQ-labeled peptides were fractionated by high-accuracy liquid chromatography-mass spectrometry (LC-MS). Cell apoptosis and differentially expressed proteins was detected by flow cytometry (FCM), quantitative real-time polymerase chain reaction (qRT-PCR), and western blotting, respectively. The apoptosis of the IL-1β - induced SW1353 cells treated with ASG-IV was greatly inhibited. Bioinformatics analysis revealed that gamma actin 1 (ACTG1) and Yes Associated Protein 1 (YAP1), participating in the Hippo signaling pathway and Vitronectin (VTN) and Collagen Type I Alpha 1 Chain (COL1A1), involving in the extracellular matrix (ECM)-receptor interaction signaling pathway, were all significantly up-regulated in the IL-1β - induced SW1353 cells after treatment with ASG-IV. The qRT-PCR and Western blotting results confirmed the up-regulation of these four genes. ASG-IV played a positive role in human osteoarthritic chondrocyte apoptosis, possibly through modulation of the Hippo signaling pathway by up-regulating YAP1 and ACTG1 expression, and also by up-regulating VTN and COL1A1, which are involved in the ECM-receptor interaction pathway. Taken together, all the results suggested that ASG-IV had a novel therapeutic potential for the treatment of OA.
28501006	0	39	Liquid chromatography-mass spectrometry	T058	UMLS:C0872318
28501006	47	79	quantitative proteomics analysis	T058	UMLS:C0022885
28501006	60	70	proteomics	T091	UMLS:C0872252
28501006	88	113	chondroprotective effects	T033	UMLS:C0243095
28501006	117	133	astragaloside IV	T103	UMLS:C0378018
28501006	137	151	interleukin-1β	T103	UMLS:C0021753
28501006	162	191	SW1353 chondrocyte-like cells	T017	UMLS:C1516497
28501006	192	203	Chondrocyte	T017	UMLS:C0225369
28501006	204	213	apoptosis	T038	UMLS:C0162638
28501006	239	250	progression	T038	UMLS:C0242656
28501006	254	268	Osteoarthritis	T038	UMLS:C0029408
28501006	270	272	OA	T038	UMLS:C0029408
28501006	294	299	drugs	T058	UMLS:C3687832
28501006	341	343	OA	T038	UMLS:C0029408
28501006	374	390	Astragaloside IV	T103	UMLS:C0378018
28501006	392	398	ASG-IV	T103	UMLS:C0378018
28501006	509	520	chondrocyte	T017	UMLS:C0225369
28501006	598	604	ASG-IV	T103	UMLS:C0378018
28501006	608	619	chondrocyte	T017	UMLS:C0225369
28501006	620	629	apoptosis	T038	UMLS:C0162638
28501006	631	721	Isobaric Tags For Relative And Absolute Quantitation (iTRAQ)-based quantitative proteomics	T058	UMLS:C0022885
28501006	711	721	proteomics	T091	UMLS:C0872252
28501006	749	755	detect	T033	UMLS:C0442726
28501006	764	772	proteins	T103	UMLS:C0033684
28501006	776	805	SW1353 chondrocyte-like cells	T017	UMLS:C1516497
28501006	823	829	ASG-IV	T103	UMLS:C0378018
28501006	833	847	interleukin-1β	T103	UMLS:C0021753
28501006	849	854	IL-1β	T103	UMLS:C0021753
28501006	859	865	ASG-IV	T103	UMLS:C0378018
28501006	868	873	IL-1β	T103	UMLS:C0021753
28501006	879	901	iTRAQ-labeled peptides	T103	UMLS:C0030956
28501006	923	976	high-accuracy liquid chromatography-mass spectrometry	T058	UMLS:C0872318
28501006	978	983	LC-MS	T058	UMLS:C0872318
28501006	986	1000	Cell apoptosis	T038	UMLS:C0162638
28501006	1005	1038	differentially expressed proteins	T103	UMLS:C0033684
28501006	1043	1051	detected	T033	UMLS:C0442726
28501006	1055	1069	flow cytometry	T058	UMLS:C0016263
28501006	1071	1074	FCM	T058	UMLS:C0016263
28501006	1077	1125	quantitative real-time polymerase chain reaction	T062	UMLS:C3179034
28501006	1127	1134	qRT-PCR	T062	UMLS:C3179034
28501006	1141	1157	western blotting	T058	UMLS:C0005863
28501006	1177	1186	apoptosis	T038	UMLS:C0162638
28501006	1194	1199	IL-1β	T103	UMLS:C0021753
28501006	1210	1222	SW1353 cells	T017	UMLS:C1516497
28501006	1236	1242	ASG-IV	T103	UMLS:C0378018
28501006	1266	1280	Bioinformatics	T091	UMLS:C1140694
28501006	1266	1289	Bioinformatics analysis	T058	UMLS:C0022885
28501006	1304	1317	gamma actin 1	T103	UMLS:C3884655
28501006	1319	1324	ACTG1	T103	UMLS:C3884655
28501006	1330	1354	Yes Associated Protein 1	T103	UMLS:C1318127
28501006	1356	1360	YAP1	T103	UMLS:C1318127
28501006	1384	1407	Hippo signaling pathway	T038	UMLS:C3158583
28501006	1412	1423	Vitronectin	T103	UMLS:C4281807
28501006	1425	1428	VTN	T103	UMLS:C4281807
28501006	1434	1463	Collagen Type I Alpha 1 Chain	T103	UMLS:C0972255
28501006	1465	1471	COL1A1	T103	UMLS:C0972255
28501006	1581	1593	up-regulated	T038	UMLS:C0041904
28501006	1601	1606	IL-1β	T103	UMLS:C0021753
28501006	1617	1629	SW1353 cells	T017	UMLS:C1516497
28501006	1651	1657	ASG-IV	T103	UMLS:C0378018
28501006	1663	1670	qRT-PCR	T062	UMLS:C3179034
28501006	1675	1691	Western blotting	T058	UMLS:C0005863
28501006	1714	1727	up-regulation	T038	UMLS:C0041904
28501006	1742	1747	genes	T017	UMLS:C0017337
28501006	1749	1755	ASG-IV	T103	UMLS:C0378018
28501006	1765	1778	positive role	T033	UMLS:C1446409
28501006	1782	1787	human	T204	UMLS:C0086418
28501006	1788	1824	osteoarthritic chondrocyte apoptosis	T038	UMLS:C0162638
28501006	1803	1814	chondrocyte	T017	UMLS:C0225369
28501006	1861	1884	Hippo signaling pathway	T038	UMLS:C3158583
28501006	1888	1901	up-regulating	T038	UMLS:C0041904
28501006	1902	1906	YAP1	T103	UMLS:C1318127
28501006	1911	1916	ACTG1	T103	UMLS:C3884655
28501006	1917	1927	expression	T038	UMLS:C0017262
28501006	1941	1954	up-regulating	T038	UMLS:C0041904
28501006	1955	1958	VTN	T103	UMLS:C4281807
28501006	1963	1969	COL1A1	T103	UMLS:C0972255
28501006	2078	2084	ASG-IV	T103	UMLS:C0378018
28501006	2140	2142	OA	T038	UMLS:C0029408